Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Ionis scores ‘breakthrough’ rare disease approval
The FDA has approved Ionis' Zanvastro, the first medicine for Alexander disease and a first step in Ionis' journey to building a solo neuro franchise.
Darren Incorvaia
Sep 4, 2026 11:18am
Daiichi unit recalls 3 epinephrine lots after complaints in US
Sep 4, 2026 11:12am
The people who stayed with the problem
Sep 4, 2026 10:15am
Fierce Biotech
A year after Big Pharma’s pull-back from the UK, what’s changed?
Sep 4, 2026 10:00am
The Oral GLP-1 Tracker: Wegovy pill, Foundayo both grow
Sep 4, 2026 9:39am
Roche, GSK, Novartis, MFN, Akeso and more—Fierce Pharma Asia
Sep 4, 2026 8:52am
More News
Fresenius Medical Care hit with FDA warning letter at Utah plant
Sep 3, 2026 3:31pm
Novartis teams with Olympian Laviai Nielsen on MS campaign
Sep 3, 2026 2:19pm
FDA docs shed light on contentious nod for Replimune's Trudiqev
Sep 3, 2026 12:10pm
CMI forms new specialty communications business unit
Sep 3, 2026 11:35am
